首页> 外文期刊>Frontiers in Microbiology >En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
【24h】

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach

机译:通往欧洲兽药敏感性试验临床断点的途径:解释VetCAST方法的立场文件

获取原文
获取外文期刊封面目录资料

摘要

VetCAST is the EUCAST sub-committee for Veterinary Antimicrobial Susceptibility Testing. Its remit is to define clinical breakpoints (CBPs) for antimicrobial drugs (AMDs) used in veterinary medicine in Europe. This position paper outlines the procedures and reviews scientific options to solve challenges for the determination of specific CBPs for animal species, drug substances and disease conditions. VetCAST will adopt EUCAST approaches: the initial step will be data assessment; then procedures for decisions on the CBP; and finally the release of recommendations for CBP implementation. The principal challenges anticipated by VetCAST are those associated with the differing modalities of AMD administration, including mass medication, specific long-acting product formulations or local administration. Specific challenges comprise mastitis treatment in dairy cattle, the range of species and within species breed considerations and several other variable factors not relevant to human medicine. Each CBP will be based on consideration of: (i) an epidemiological cut-off value (ECOFF) – the highest MIC that defines the upper end of the wild-type MIC distribution; (ii) a PK/PD breakpoint obtained from pre-clinical pharmacokinetic data [this PK/PD break-point is the highest possible MIC for which a given percentage of animals in the target population achieves a critical value for the selected PK/PD index ( f AUC/MIC or f T > MIC)] and (iii) when possible, a clinical cut-off, that is the relationship between MIC and clinical cure. For the latter, VetCAST acknowledges the paucity of such data in veterinary medicine. When a CBP cannot be established, VetCAST will recommend use of ECOFF as surrogate. For decision steps, VetCAST will follow EUCAST procedures involving transparency, consensus and independence. VetCAST will ensure freely available dissemination of information, concerning standards, guidelines, ECOFF, PK/PD breakpoints, CBPs and other relevant information for AST implementation. Finally, after establishing a CBP, VetCAST will promulgate expert comments and/or recommendations associated with CBPs to facilitate their sound implementation in a clinical setting.
机译:VetCAST是EUCAST兽医抗微生物药敏性测试小组委员会。其职责是为欧洲兽药中使用的抗菌药物(AMD)定义临床断点(CBP)。本立场文件概述了程序,并概述了科学的选择方案,以解决为动物物种,原料药和疾病状况确定特定CBP的挑战。 VetCAST将采用EUCAST方法:第一步将是数据评估;然后就CBP做出决定的程序;最后发布有关CBP实施的建议。 VetCAST预期的主要挑战是与AMD给药方式不同有关的挑战,包括大规模药物治疗,特定的长效产品配方或局部给药。具体挑战包括奶牛乳腺炎的治疗,物种范围和物种品种方面的考虑以及其他与人类医学无关的其他可变因素。每个CBP将基于以下考虑:(i)流行病学临界值(ECOFF)–定义野生型MIC分布上限的最高MIC; (ii)从临床前药代动力学数据获得的PK / PD断点[此PK / PD断点是可能的最高MIC,对于该百分比,目标种群中给定百分比的动物达到所选PK / PD指数的临界值(f AUC / MIC或f T> MIC)]和(iii)在可能的情况下,是一项临床临界值,即MIC与临床治愈之间的关系。对于后者,VetCAST承认兽医学中此类数据的匮乏。如果无法建立CBP,VetCAST将建议使用ECOFF作为替代。对于决策步骤,VetCAST将遵循EUCAST程序,涉及透明度,共识和独立性。 VetCAST将确保免费提供有关标准,指南,ECOFF,PK / PD断点,CBP和其他与AST实施相关的信息。最后,在建立CBP之后,VetCAST将发布与CBP相关的专家意见和/或建议,以促进其在临床环境中的合理实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号